Skip to main content
Premium Trial:

Request an Annual Quote

Across the Board Growth Pushes BD's Q4 Profits up 44 Percent

NEW YORK (GenomeWeb News) — Becton Dickinson today said that fiscal fourth-quarter revenues rose 13 percent as R&D spending increased 22 percent and profit soared 44 percent.
Total receipts for the three months ended Sept. 30 increased to $1.65 billion from $1.46 billion year over year.
BD said revenues from its Diagnostics segment grew 16 percent to $497.9 million, while Biosciences revenue rose 14 percent to $284.9 million. Revenue from the Medical segment rose 11 percent to $868.3 million.  
BD’s R&D spending for the quarter rose to $100.4 million from $82.4 million year over year.
The firm’s profits for the quarter increased to $251 million from $174 million in the year-ago period.
For full-year 2007, BD reported revenue of $6.4 billion, an 11 percent increase over revenue of $5.7 billion in fiscal 2006. The firm’s 2007 profit was $881.3 million, a 17.1 percent gain on last year’s net earnings of $752.3 million.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.